Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 51407-742

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 51407-742). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-742-10ol (Esomeprazole Magnesium 20 mg)

Label for Esomeprazole Magnesium delayed-release capsules, USP, 20 mg strength. The label indicates a package size of 1,000 capsules, marketed by GSMS, Incorporated. It includes storage instructions at 20-25°C and warnings to keep medication out of children’s reach and container tightly closed. The label also provides a barcode and directs pharmacists to dispense the medication guide.*

FDA Label Image

51407-743-10ol (Esomeprazole Magnesium 40 mg)

Label for Esomeprazole Magnesium delayed-release capsules, USP, 40 mg strength. The label indicates a package size of 1,000 capsules and includes instructions for pharmacists to dispense the Medication Guide. It shows storage temperature instructions and notes that the product is marketed by GSMS, Incorporated in Camarillo, CA. The label includes a barcode and references the NDC 51407-743-10.*

FDA Label Image

Spl-figure-2 (Spl Figure 2)

This line graph depicts the percentage of patients maintaining a specified condition over a 6-month period with scheduled visits marked at each month. It compares Esomeprazole Magnesium capsules at dosages of 10 mg, 20 mg, and 40 mg versus a placebo, showing percent maintained on the y-axis and time in months on the x-axis.*

FDA Label Image

Spl-figure-3 (Spl Figure 3)

A line graph showing the percent of a measured variable maintained over six months for Esomeprazole magnesium at 40 mg, 20 mg, 10 mg doses, and placebo. The y-axis represents percent maintained, and the x-axis represents months, with scheduled visits marked. Both the 40 mg and 20 mg doses maintain close to 100% over time, whereas 10 mg and placebo show a decline.*

FDA Label Image

Spl-figure-4 (Spl Figure 4)

A line chart showing the percent of patients symptom-free over 28 days comparing Esomeprazole Magnesium 40 mg, 20 mg, and placebo groups. The x-axis represents diary days from 0 to 28, and the y-axis shows the percent of symptom-free patients from 0% to 100%. Data points for each group are plotted with distinct markers and lines.*

FDA Label Image

Spl-figure-5 (Spl Figure 5)

Line chart depicting the percent of patients symptom-free over 28 diary days comparing Esomeprazole magnesium 40 mg, 20 mg, and placebo groups. The vertical axis shows percent symptom-free patients, while the horizontal axis shows diary days from 0 to 28. The chart includes three data series with different markers for each group.*

FDA Label Image

Spl-structure (Spl Structure)

Chemical structure of esomeprazole magnesium showing the molecular arrangement including aromatic rings, sulfur, nitrogen atoms, and magnesium ion complex.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.